Intra-individual variability over time in serum cytokine levels among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Cytokine

Volumn 56, Issue 2, 2011, Pages 145-148

  Hofmann, Jonathan N ^a   Yu, Kai ^a   Bagni, Rachel K ^b   Lan, Qing ^a   Rothman, Nathaniel ^a   Purdue, Mark P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Cancer; Cytokines; Inflammation; Serum; Variability

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; COLORECTAL CANCER; CORRELATION COEFFICIENT; FEMALE; HUMAN; INTRAINDIVIDUAL VARIABILITY; LIMIT OF DETECTION; LUNG CANCER; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; STATISTICAL PARAMETERS;

AGED; COLORECTAL NEOPLASMS; CYTOKINES; FEMALE; HUMANS; LIMIT OF DETECTION; LUNG NEOPLASMS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 80053313356     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.06.012     Document Type: Article

References (20)

1. Shacter E., Weitzman S.A. Chronic inflammation and cancer. Oncology 2002, 16:217-226.
2. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117:1175-1183.
3. Ho G.Y., Xue X.N., Burk R.D., et al. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2years in young women. Cytokine 2005, 30:1-6.
4. Kaplan R.C., Ho G.Y., Xue X., et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 2007, 16:1291-1293.
5. Gu Y., Zeleniuch-Jacquotte A., Linkov F., et al. Reproducibility of serum cytokines and growth factors. Cytokine 2009, 45:44-49.
6. Gohagan J., Prorok P., Levin D., et al. The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000, 21:249S-406S.
7. Hayes R.B., Reding D., Kopp W., et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000, 21:349S-355S.
8. Gunter MJ, Cross AJ, Huang WY, et al. A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev. doi: doi:10.1158/1055-9965.EPI-10-1099.
9. Hofmann J.N., Yu K., Horst R.L., et al. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2010, 19:927-931.
10. Lubin J.H., Colt J.S., Camann D., et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004, 112:1691-1696.
11. Rosner B. Fundamentals of Biostatistics 2000, Duxbury, Pacific Grove, CA. 5th ed.
12. Sites C.K., Toth M.J., Cushman M., et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002, 77:128-135.
13. Rosner B., Spiegelman D., Willett W.C. Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 1992, 136:1400-1413.
14. Saberi Hosnijeh F., Krop E.J., Scoccianti C., et al. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2010, 19:1577-1584.
15. Gu Y., Shore R.E., Arslan A.A., et al. Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control 2010, 21:1323-1333.
16. Cava F., Gonzalez C., Pascual M.J., et al. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 2000, 12:1423-1425.
17. Gonzalez C., Cava F., Ayllon A., et al. Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clin Chem Lab Med 2001, 39:836-841.
18. Lee S.A., Kallianpur A., Xiang Y.B., et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 2007, 16:2464-2470.
19. Thavasu P.W., Longhurst S., Joel S.P., et al. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992, 153:115-124.
20. House R.V. Cytokine measurement techniques for assessing hypersensitivity. Toxicology 2001, 158:51-58.